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1143-155 Warfarin Therapy Improves Clinical Outcome of 
Kawasaki Disease Patients With Giant Coronary 
Aneurysm 
Yoke Suqahara Masahiro Ishii, Hirohiko Koizuml, Kimiyasu Egaml. Hiromi Muta, Teiji 
Akagi, Hirohisa Kate. Toyojiro Matsuishi. Kurume University, Kurume, Japan 
Background Giant coronary aneurysms (GA) increase the risk of sudden death due to 
myccardial Infarction (Ml) caused by massive thrombosis. Anticoagulation therapy Using 
wariarin for Kawasaki drsease (KD) patients (pts) with GA is controversial. We investi- 
gated whether warfarin therapy improve the clinical outcome of KD pts with GA. Methods 
We followed 2031 KD pts smce 1973 at Kurume University hospital. Fifty-one pts (37 
male and 14 female) were retrospectively studied. Giant aneurysms were diagnosed by 
coronary angiogram in all pts. Patients divided into 2 groups, Group A; consisted 29 car- 
onary branches in 17 pts treated with combination of warfarin with aspirin, Group B; con- 
sisted of 60 coronary branches I” 34 pts treated with aspirin alone. Results Mean age at 
diagnosis was not significantly different (3.1 year vs. 2.6 year, p=NS). Angiograms were 
performed 4+2 times during follow-up period. Combination therapy of warfarin and aSpi- 
rin significantly reduced the incidence of Ml compared wth aspirin alone (aspirin alone 
25% vs. warfann X4%, p<O.O5). Stenotic lesions developed in 31 branches, including 10 
branches (34%) in Group A, and Including 21 branches (35%) in Group 8. The incidence 
of stenosis was not significantly different between 2 groups. The incidence of recanaliza- 
tion was not significantly different between 2 groups (Group A; 4 branches vs. Group 8; 6 
branches). The number of requwing CAEG surgery (2 branches 6.9 %) in patients treated 
with combination of warfarin with aspirin tend to be smaller than those (10 branches, 
16.7%) of patients treated wth aspirin alone. However, there was no significantly differ- 
ent between 2 groups, In 1 patient treated with aspirin alone, sudden death occurred by 
Ml due to coronary thrombosis I” acute phase. However, no pts treated with combination 
of warfarin with aspirin died suddenly in acute phase. Conclusions: The combination of 
warfarin with aspirin therapy improved the clinlcal outcome of KD pts with GA. The war- 
farin therapy reduced the incidence of Ml and prevents the sudden death. 
1143-156 Increased Risk of D-Transposition of the Great Arteries 
Associated With Maternal Residential Proximity to 
Hazardous Waste Sites 
Sadia Ghaffar. Charlotte Hobbs, University of Arkansas Medical Sciences, Little Rock, 
AR, Arkansas Center for Birth Defects, Little Rock, AR 
Background: Although it is believed that genetic, familial, and environmental factors 
contribute in a multifactorial fashion to cause congenital heart defects (CHD), several 
laboratory and epidemiologic studies have raised the suspicion that the environment, and 
toxic chemicals in particular, play a substantial role. Using data from the Arkansas 
Reproductive Health Monitoring System and the Environmental Protection Agency, we 
investigated whether maternal residential proximity to hazardous waste sites increases 
the risk for congenital heari defects in Arkansas. 
Methods In a case-control study, cardiac anomalies among 592 births throughout 
Arkansas from January 1996-June 2002 were matched by year of birth to 1911 births 
wth no CHDs (controls). We identified the locations of 222 hazardous waste sites and 12 
National Priority List (NPL) sites that were functional throughout the study period. Prox- 
imity to hazardous waste sites or NPL sites was used as a surrogate for actual exposure. 
The measure of proximrty was based on the measured distance between maternal resi- 
dence for cases and controls and the closest hazardous waste site or NPL site, using 
ArcView geographical software. 
Results We found an increased risk for d-Transposition of the Great Arteries (d-TGA) in 
association with maternal residence within 1 mile of hazardous waste sites (odds 
ratio=3.7, p value=0.045). There was no statistically significant relationship between the 
prevalence of other specific heart defects and maternal residence. 
Conclusion: Previous studies have documented the association of d-TGA with house- 
hold pesticide use. This is exciting additional data from our population and an important 
step I” strengthening the hypothesis that exposure to hazardous waste sites increases 
the risk of certain CHDs. The results of this study also suggest that environmental scor- 
ing systems, linkage of large population databases, and proximity mapping using com- 
putenzed geographic coordmates are useful for evaluating other birth defects and 
diseases for their association with toxx waste site exposure. 
1143-157 Factors Associated With Prolonged Pleural Effusion8 
Following the Fontan Procedure 
lsmee A. Williams, Thomas J. Start, Jan Cluaegebeur, Welton M. Gersony, Daphne T. 
Hsu, Columbia University, New York, NY 
Background: Despite advances in surgical and post-operative management, prolonged 
pleural effusions (PE) remain a major complication post-Fontan and are associated with 
significant morbidity. Factors influencing the duration of PE remain unclear, including the 
effect of fenestration. 
Methods: All patients (pts) who underwent a modified Fontan procedure by a single sur- 
geon between 2/00 and l/O2 were reviewed. The duration of significant PE was corre- 
lated with demographics, cardiac anatomy, and operative and post-operative (post-op) 
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course. Pts who had prolonged PE and required a chest-tube (CT) > 9 days post-op were 
compared to those who did not. 
Results: Modified Fontan procedure (non-fenestrated-22 pts, fenestrated-16 pts) was 
performed in 41 pts with a mean age of 4.1+ 1.6 yrs (range 1.6-l 1.5); post-op data was 
unavailable in 1 pt. Mean duration of PE was 10 + 4 days, (median 9 days), with 16/40 
(40%) pts requiring a CT z 9 days. No significant association was found between pro- 
longed PE and ventricular anatomy, weight at surgery, the presence of collaterals, sea- 
son of operation, bypass or crossclamp time, the need for pulmonary artery repair or 
higher CVP on post-op day 1. Duration of PE was not significantly different in pts who 
had a fenestration compared to those who were non-fenestrated (9.4 * 2.4 days vs. 10.6 
k5.6 days, ~~0.4). Analysis of PE fluid was performed at 6-4 days post-op and triglycer- 
ide and lymphocyte count were not associated wth prolonged PE. Prolonged PE was 
associated with older age at Fontan (4.7 + 2.4 yrs vs. 3.6 + 1 .O yrs, p=O.O4) and higher 
mean CT output on post-op day 1 (19~ 14 cc/kg/day vs. 10 + 4 cckglday. ~~0.01) corn- 
pared to those without prolonged PE. Pts with prolonged PE had post-op feedings initi- 
ated later (5.22 7.6 days vs. 1.72 0.7 days, p =0.03) than pts without prolonged PE. 
Conclusion: Older age at time of surgery and higher CT output on post-op day 1 were 
associated with prolonged PE after the modified Fontan procedure. The presence of a 
fenestration was not associated with PE. Prolonged PE was not associated with the pres- 
ence of chyle or early feeding. Further investigation of the impact of dietary intervention 
on the duration of PE is needed. 
1143-158 Preliminary Experience With Bosentan in Children With 
Primary Pulmonary Hypertension 
Daniel J. Penny. Michelle Rose, Sarah Wilson, Andrew M. Davis, Robert G. Weintraub, 
Royal Children’s Hospital, Melbourne, Australia 
Background:Childhood primary pulmonary hypertension (PPH) is a rapidly progressive 
disease with a median survival of 15 months from presentation. The dual receptor antag- 
onist Bosentan has recently been shown to lower pulmonary vascular resistance (PVR) 
and improve exercise tolerance in adults with PPH. As yet there is no published data 
about the effectiveness of Bosentan I” children. 
Methods: Since September 2001 we have administered Bosentan to 7 consecutive chil- 
dren with PPH. The starting dose was 31.25mg twice daily for children weighing c40kg 
and 62.5mg twice daily in those >40kg. The medical protocol involves exclusion of known 
etiologies, documentation of serial PVR and assessment of exercise capacity. 
Results: Familial PPH was present in 3 of 7 subjects. Four children were having synco- 
pal episodes and one was chronically hospitalized with refractory congestive heart failure 
(CHF). One child was receiving Flolan. The median (range) age at the time of corn- 
mencement of therapy was 9.5 (2.1-14.7) years. The median PA pressure prior to com- 
mencing Bosentan was 53mmHg (95% Cl: 40.7.70.6), with a median aortic pressure of 
50mmHg (95%CI: 45.2-56.1). The median transpulmonary gradient was 40mmHg 
(95%CI: 26.5-54.6) with a median cardiac index of 2.66Umin/m’(95%CI: 2.03-3.15) and 
a median PVR index of 1&3U.&(95%CI: 10.60-21.97). The median (range) duration of 
follow-up has been 6.0 (4.0-11.5) months. All patients are alive and 6 of 7 patients 
(including the one with CHF) have improved symptomatically with an increase in mean 
NYHA class from 2.6 to 2.1. Three of 4 children who have already undergone follow-up 
cardiac catheterization have shown a fall in PVR index from a median of 16.4U.m’ to 
iO.lU.m*. while one other child has had a further increase in PVR index, and another 
has commenced Flolan in addition to Bosentan. There have been no adverse effects and 
no deterioration in liver function tests attributable to medical therapy. 
Conclusions: In the majority of younger children with PPH, commencement of Bosentan 
is associated with an improvement in symptomatic status and a fall in PVR. Our prelimi- 
nary experience with Bosentan suggests that it is a promising therapeutic agent in child- 
hood PPH. 
1143-159 The Spectrum of Left Ventricular Noncompaction in 
Children With Congenital Heart Disease 
Marina L. Huqhes James L. Wilkinson, Robert G. Weintraub, Royal Children’s Hospital, 
Melbourne, Australia 
Background: Left ventricular non-compaction (LVNC) is increasmgly recognised as a 
cause of paediatric cardiomyopathy. The diagnosis is image-based and qualitative. This 
study examines the prevalence, relying on angiographic assessment, and explores the 
outcomes for children with LVNC and congenital heart disease (CHD). 
Methods: A systematic review was undertaken of all children who had a LV angiogram 
performed in our centre between 1994 and 2000. Angiograms were screened for LVNC 
by one observer. Those exhibiting pre-defined criteria, including characteristic prominent 
LV trabeculatlon, were reassessed by two further independent observers. LVNC was 
diagnosed when agreement was unanimous. Children referred solely for cardiac trans- 
plantation were excluded. 
Results: 1626 LV angiograms were undertaken in 1539 patients during the study period, 
and of these 32 (13 male) were newly recognised to have LVNC. The incidence in this 
population was 2.1% (95% Cl: 1.4-2.8%). Of these, 44% had hypoplastic right heart right 
heart syndromes or other forms of single LV, 34% had atrial or ventricular septal defects, 
13% had Tetralogy of Fallot, 6% had truncus arteriosus and 3% had left heart obstructive 
lesions. Two patients with LVNC had died suddenly, and 3 died or were transplanted for 
progressive LV dysfunction. Survival at 20 years of age was 30% for children with LVNC 
compared to 93% among 746 children with the same cardiac malformations without 
LVNC (Log Rank test p = 0.002). Of 27 patients still alive with LVNC and CHD, 6 (22%) 
have LV systolic dysfunction or restrictive physiology at latest follow-up. None are known 
to have had embolic phenomena. 
Conclusion: LVNC is often unrecognised, and may occur in 2% of children with CHD 
undergoing angiography. Late cardiac dysfunction and worse long-term survival warrants 
additional scrutiny for LVNC in children with congenital heart disease. 
